Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Puslapis 1 nuo 35 rezultatus
Soy Estrogen Alternative Study (SEA)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND:
The results of many studies indicate that estrogen replacement therapy (ERT) reduces the risk of coronary heart disease (CHD) in postmenopausal women. However, less than 9 percent of these women choose to take ERT because of unwanted side effects and concerns about increased risk of
Safety Study of SEA-CD40 in Cancer Patients
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The study will be conducted in the following parts:
Part A: Intravenous (IV) monotherapy dose-regimen finding for solid tumors -- Dose-escalation, and possible dose-interval modification to lengthen the treatment cycle, to define the IV SEA-CD40 monotherapy maximum tolerated dose (MTD) and/or the
A Safety Study of SGN-TGT (SEA-TGT) in Patients With Advanced Cancer
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The SEA CHANGE Study: A Self Management Intervention for Head and Neck Cancer Survivors
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Head and neck cancer (HNC) and its treatment are associated with specific challenges such as facial disfigurement and impairments in speech, breathing and swallowing, and can have a negative impact on well-being. Self-management interventions can provide people with skills to deal with
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This is a phase 1, open-label, multicenter, dose-escalation, and cohort expansion study designed to evaluate the safety, tolerability, PK, and antitumor activity of SEA-CD70 in adults with myeloid malignancies. The study will be conducted in up to 3 parts.
Part A is a dose escalation cohort designed
Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT Study
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Multiple myeloma is a cancer that evolves from a state known as Monoclonal Gammopathy of Undetermined Significance (MGUS), defined by parameters of M spike and bone marrow. After evolution to myeloma, patients may be asymptomatic, that is, without any endorgan disease of hypercalcemia, renal
A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Multiple myeloma is a cancer that evolves from a state known as Monoclonal Gammopathy of Undetermined Significance (MGUS), defined by parameters of M spike and bone marrow. After evolution to myeloma, patients may be asymptomatic, that is, without any endorgan disease of hypercalcemia, renal
Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The object of this study is to compare the genotypic and phenotypic differences between south and north shore of the mediterranean sea.
An Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Trial (MK-0653A-043-10)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The SEAS Follow-up Study is a 21 month extension to the base protocol (2004_050, MK0653A-043; NCT00092677). The main objective of the extension is to observe the incidence rates of cancer, total mortality, and mortality due to cancer over a 21 month follow-up period (from 04-March 2008 to
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
PRIMARY OBJECTIVE:
I. Determine the initial efficacy of electroacupuncture (EA) in reducing chronic pain in women following treatment for breast cancer.
SECONDARY OBJECTIVES:
I. Determine if EA produces greater improvement in physical functional mobility as compared to sham electroacupuncture (SEA)
Stomach and Esophageal Cancers in Northern Iran
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This case-control study (the first phase of the GEMINI project) is primarily focused on exploring the etiology (etiologies) of squamous cell carcinoma of the esophagus in northern Iran.
Esophageal and gastric cancers, together, are responsible for more than 1,000,000 annual deaths in the world. In
Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVES:
- Determine the feasibility of implementing an acupressure therapy for the prevention of chemotherapy-associated nausea in children with cancer.
- Test the hypothesis that acupressure bands will prevent chemotherapy-associated nausea and vomiting in children, when compared to placebo
PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This is a Phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer. Severe COVID-19 is defined as confirmed disease in patients who are hospitalized with hypoxia
Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Study Groups If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 groups. You will have an equal chance of being assigned to either group.
If you are in Group 1, you will receive paclitaxel for 4 cycles. You also will be
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
